Therapeutics Lifecycle SIG

Join us for the first meeting on our new schedule. We’ll review the SIG’s work to date and discuss priorities for 2024.

The Therapeutic Lifecycle SIG focuses holistically on the full lifecycle of therapeutic development, from clinical trials to in-market use. Initial work will focus on clinical research, regulatory submission, in-market pharmaceuticals, and connecting research technology solutions to in-market technology solutions.